Gossamer Bio Insider Trades
NASDAQ: GOSSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Gossamer Bio insider activity
Over the last 12 months, Gossamer Bio insiders reported 6 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Smith Robert Paul JR (Chief Commercial Officer) reporting a transaction in 93,750 shares on Jan 2, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GOSS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
GOSS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jan 2, 2026 | Christian WaageEVP, Tech Ops and Admin | Award | 84,500 | — | Form 4 |
| Jan 2, 2026 | Peterson CarynEVP, Regulatory Affairs | Award | 84,500 | — | Form 4 |
| Jan 2, 2026 | Aranda RichardChief Medical Officer | Award | 93,750 | — | Form 4 |
| Jan 2, 2026 | Giraudo BryanCOO/CFO | Award | 115,750 | — | Form 4 |
| Jan 2, 2026 | Hasnain FaheemPresident & CEO | Award | 280,000 | — | Form 4 |
| Jan 2, 2026 | Smith Robert Paul JRChief Commercial Officer | Award | 93,750 | — | Form 4 |
| Oct 1, 2025 | Peterson CarynEVP, Regulatory Affairs | Award | 125,000 | — | Form 4 |
| Oct 1, 2025 | Giraudo BryanCOO/CFO | Award | 181,250 | — | Form 4 |
| Oct 1, 2025 | Christian WaageEVP, Tech Ops and Admin | Award | 125,000 | — | Form 4 |
| Oct 1, 2025 | Hasnain FaheemPresident & CEO | Award | 437,500 | — | Form 4 |
| Oct 1, 2025 | Aranda RichardChief Medical Officer | Award | 162,500 | — | Form 4 |
| Oct 1, 2025 | Smith Robert Paul JRChief Commercial Officer | Award | 162,500 | — | Form 4 |
| Aug 19, 2025 | Milligan SandraDirector | Buy | 26,050 | $50.02K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4